What do YOU think about FDA's recent actions on diagnostics and lab-developed tests?
's feature report
on reactions from the medical community on the most recent steps by the U.S. Food and Drug Administration that will affect approvals of companion diagnostics, and will likely lead to more oversight of LDTs. What do YOU think?
|Will these actions slow down the development of novel drugs and therapeutics?|